NFKB1 and hereditary spastic paraplegia: Lakhsmi et al. revealed that HSP treatment in Swiss albino mice prevents cancer formation by alleviating LPO, modulating antioxidants enzymes like decreased NF-kB, PCNA, and CYP1A1.